West Pharmaceutical Services Inc SEC filings WST
West Pharmaceutical Services Inc has 1,001 filings in SEC EDGAR's recent list, going back to Aug 14, 2014. Its latest annual report, Form 10-K, was filed on Feb 17, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 29, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 29, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Oct 29, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Oct 29, 2026 | Oct 29, 2026 |
| 8-K |
Current report
Material agreement, Agreement ended, New debt
|
Oct 26, 2026 | Oct 26, 2026 |
| 4 | Insider transaction | Oct 2, 2026 | Sep 30, 2026 |
| 4 | Insider transaction | Sep 15, 2026 | Sep 11, 2026 |
| 4 | Insider transaction | Sep 10, 2026 | Sep 8, 2026 |
| 4 | Insider transaction | Sep 10, 2026 | Sep 8, 2026 |
| 3 | Initial insider ownership | Sep 10, 2026 | Aug 31, 2026 |
| 4 | Insider transaction | Aug 12, 2026 | Aug 11, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 6, 2026 | — |
| 10-Q | Quarterly report | Jul 23, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jul 23, 2026 | Jul 23, 2026 |
| 8-K |
Current report
Material agreement
|
Jul 14, 2026 | Jul 14, 2026 |
| 4 | Insider transaction | Jul 1, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jun 1, 2026 | May 31, 2026 |
| 8-K/A | Amended current report | May 20, 2026 | May 7, 2026 |
| 4 | Insider transaction | May 14, 2026 | May 12, 2026 |
| SD | Specialized disclosure (conflict minerals) | May 13, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure
|
May 11, 2026 | May 7, 2026 |
| 144 | Notice of proposed sale | May 7, 2026 | — |
| 4 | Insider transaction | May 6, 2026 | May 4, 2026 |
| 4 | Insider transaction | May 6, 2026 | May 4, 2026 |
| 4 | Insider transaction | May 6, 2026 | May 4, 2026 |
| 4 | Insider transaction | May 6, 2026 | May 4, 2026 |
| 4 | Insider transaction | May 6, 2026 | May 4, 2026 |
| 4 | Insider transaction | May 6, 2026 | May 4, 2026 |
| 4 | Insider transaction | May 6, 2026 | May 4, 2026 |
| 4 | Insider transaction | May 6, 2026 | May 4, 2026 |
| 4 | Insider transaction | May 6, 2026 | May 4, 2026 |
| 4 | Insider transaction | May 6, 2026 | May 4, 2026 |
| 8-K |
Current report
Shareholder vote results
|
May 5, 2026 | May 4, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Apr 30, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Apr 29, 2026 | — |
| 4 | Insider transaction | Apr 29, 2026 | Apr 27, 2026 |
| 4 | Insider transaction | Apr 29, 2026 | Apr 27, 2026 |
| 10-Q | Quarterly report | Apr 23, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Apr 23, 2026 | Apr 23, 2026 |
| 4 | Insider transaction | Apr 1, 2026 | Mar 31, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Mar 27, 2026 | — |
| DEFA14A | Additional proxy material | Mar 12, 2026 | — |
| DEF 14A | Proxy statement | Mar 12, 2026 | May 4, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Mar 9, 2026 | Mar 9, 2026 |
| 4 | Insider transaction | Mar 3, 2026 | Mar 1, 2026 |
| 4 | Insider transaction | Mar 3, 2026 | Mar 1, 2026 |
| 4 | Insider transaction | Mar 3, 2026 | Mar 1, 2026 |
| 4 | Insider transaction | Mar 3, 2026 | Mar 1, 2026 |
| 4 | Insider transaction | Mar 3, 2026 | Mar 1, 2026 |
| 4 | Insider transaction | Mar 3, 2026 | Mar 1, 2026 |
| 4 | Insider transaction | Mar 3, 2026 | Mar 1, 2026 |
| 4 | Insider transaction | Feb 23, 2026 | Feb 20, 2026 |
| 4 | Insider transaction | Feb 23, 2026 | Feb 20, 2026 |
| 4 | Insider transaction | Feb 23, 2026 | Feb 20, 2026 |
| 4 | Insider transaction | Feb 19, 2026 | Feb 18, 2026 |
| 4 | Insider transaction | Feb 19, 2026 | Feb 17, 2026 |
| 4 | Insider transaction | Feb 19, 2026 | Feb 17, 2026 |
| 4 | Insider transaction | Feb 19, 2026 | Feb 17, 2026 |
| 4 | Insider transaction | Feb 19, 2026 | Feb 17, 2026 |
| 10-K | Annual report | Feb 17, 2026 | Dec 31, 2025 |
| 4 | Insider transaction | Feb 12, 2026 | Feb 11, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Feb 12, 2026 | Feb 12, 2026 |
| 4 | Insider transaction | Jan 5, 2026 | Dec 31, 2025 |
| 4 | Insider transaction | Dec 10, 2025 | Dec 8, 2025 |
| 3 | Initial insider ownership | Dec 10, 2025 | Dec 9, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Oct 31, 2025 | — |
| 10-Q | Quarterly report | Oct 23, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Oct 23, 2025 | Oct 23, 2025 |
| 4 | Insider transaction | Oct 2, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Officer or director change
|
Sep 11, 2025 | Sep 11, 2025 |
| S-8 | Employee stock plan registration | Aug 20, 2025 | — |
| 3 | Initial insider ownership | Aug 12, 2025 | Aug 4, 2025 |
| 4 | Insider transaction | Aug 12, 2025 | Aug 11, 2025 |
| 3 | Initial insider ownership | Aug 1, 2025 | Jul 23, 2025 |
| 10-Q | Quarterly report | Jul 24, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jul 24, 2025 | Jul 24, 2025 |
| 8-K |
Current report
Officer or director change
|
Jul 21, 2025 | Jul 21, 2025 |
| 4 | Insider transaction | Jul 1, 2025 | Jun 30, 2025 |
| SD | Specialized disclosure (conflict minerals) | May 21, 2025 | — |
| 3 | Initial insider ownership | May 14, 2025 | May 5, 2025 |
| 4 | Insider transaction | May 14, 2025 | May 12, 2025 |
| 8-K/A |
Amended current report
Officer or director change
|
May 12, 2025 | May 6, 2025 |
| 4 | Insider transaction | May 8, 2025 | May 6, 2025 |
| 4 | Insider transaction | May 8, 2025 | May 6, 2025 |
| 4 | Insider transaction | May 8, 2025 | May 6, 2025 |
| 4 | Insider transaction | May 8, 2025 | May 6, 2025 |
| 8-K |
Current report
Shareholder vote results
|
May 8, 2025 | May 6, 2025 |
| 4 | Insider transaction | May 8, 2025 | May 6, 2025 |
| 4 | Insider transaction | May 8, 2025 | May 6, 2025 |
| 4 | Insider transaction | May 8, 2025 | May 6, 2025 |
| 4 | Insider transaction | May 8, 2025 | May 6, 2025 |
| 4 | Insider transaction | May 8, 2025 | May 6, 2025 |
| 4 | Insider transaction | May 8, 2025 | May 6, 2025 |
| 4 | Insider transaction | May 8, 2025 | May 6, 2025 |
| 10-Q | Quarterly report | Apr 24, 2025 | Mar 31, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Apr 24, 2025 | — |
| 8-K |
Current report
Officer or director change
|
Apr 24, 2025 | Apr 22, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Apr 24, 2025 | Apr 24, 2025 |
| 8-K |
Current report
Officer or director change
|
Apr 14, 2025 | Apr 9, 2025 |
| 4 | Insider transaction | Apr 2, 2025 | Mar 31, 2025 |
| ARS | Annual report to shareholders | Mar 21, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Mar 21, 2025 | — |
| DEF 14A | Proxy statement | Mar 21, 2025 | May 6, 2025 |
| PRE 14A | Preliminary proxy statement | Mar 11, 2025 | May 6, 2025 |
| 8-K |
Current report
Officer or director change
|
Mar 11, 2025 | Mar 7, 2025 |
| 4 | Insider transaction | Feb 20, 2025 | Feb 18, 2025 |
| 4 | Insider transaction | Feb 20, 2025 | Feb 18, 2025 |
| 4 | Insider transaction | Feb 20, 2025 | Feb 18, 2025 |
| 4 | Insider transaction | Feb 20, 2025 | Feb 18, 2025 |
| 4 | Insider transaction | Feb 20, 2025 | Feb 18, 2025 |
| 4 | Insider transaction | Feb 20, 2025 | Feb 18, 2025 |
| 4 | Insider transaction | Feb 20, 2025 | Feb 18, 2025 |
| 10-K | Annual report | Feb 18, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Feb 13, 2025 | Feb 13, 2025 |
| 3/A | Primary document | Jan 17, 2025 | Dec 9, 2024 |
| 4/A | Primary document | Jan 17, 2025 | Dec 16, 2024 |
| 3 | Initial insider ownership | Dec 18, 2024 | Dec 9, 2024 |
| 4 | Insider transaction | Dec 18, 2024 | Dec 16, 2024 |
| 8-K |
Current report
Other events
|
Dec 13, 2024 | Dec 9, 2024 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Dec 11, 2024 | Dec 9, 2024 |
| 4 | Insider transaction | Oct 31, 2024 | Oct 29, 2024 |
| 4 | Insider transaction | Oct 31, 2024 | Oct 29, 2024 |
| 10-Q | Quarterly report | Oct 24, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Oct 24, 2024 | Oct 24, 2024 |
| S-8 POS | Filing | Oct 23, 2024 | — |
| S-8 POS | Filing | Oct 23, 2024 | — |
| 8-K |
Current report
Officer or director change
|
Oct 7, 2024 | Oct 1, 2024 |
| 4 | Insider transaction | Aug 21, 2024 | Aug 19, 2024 |
| 4 | Insider transaction | Aug 21, 2024 | May 10, 2024 |
| 4 | Insider transaction | Aug 8, 2024 | Aug 6, 2024 |
| 4/A | Primary document | Aug 8, 2024 | May 7, 2024 |
| 144 | Notice of proposed sale | Aug 6, 2024 | — |
| 10-Q | Quarterly report | Jul 25, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jul 25, 2024 | Jul 25, 2024 |
| 8-K |
Current report
Material agreement, New debt
|
Jul 8, 2024 | Jul 2, 2024 |
| 11-K | Employee savings plan report | Jun 26, 2024 | Dec 31, 2023 |
| 11-K | Employee savings plan report | Jun 26, 2024 | Dec 31, 2023 |
| 4 | Insider transaction | Jun 13, 2024 | Jun 12, 2024 |
| SD | Specialized disclosure (conflict minerals) | May 22, 2024 | — |
| 144 | Notice of proposed sale | May 10, 2024 | — |
| 4 | Insider transaction | May 9, 2024 | May 7, 2024 |
| 144 | Notice of proposed sale | May 7, 2024 | — |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Apr 26, 2024 | Apr 23, 2024 |
| 4 | Insider transaction | Apr 25, 2024 | Apr 23, 2024 |
| 4 | Insider transaction | Apr 25, 2024 | Apr 23, 2024 |
| 4 | Insider transaction | Apr 25, 2024 | Apr 23, 2024 |
| 4 | Insider transaction | Apr 25, 2024 | Apr 23, 2024 |
| 4 | Insider transaction | Apr 25, 2024 | Apr 23, 2024 |
| 4 | Insider transaction | Apr 25, 2024 | Apr 23, 2024 |
| 4 | Insider transaction | Apr 25, 2024 | Apr 23, 2024 |
| 4 | Insider transaction | Apr 25, 2024 | Apr 23, 2024 |
| 4 | Insider transaction | Apr 25, 2024 | Apr 23, 2024 |
| 10-Q | Quarterly report | Apr 25, 2024 | Mar 31, 2024 |
| 4 | Insider transaction | Apr 25, 2024 | Apr 23, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Apr 25, 2024 | Apr 25, 2024 |
| PX14A6G | Filing | Mar 19, 2024 | — |
| ARS | Annual report to shareholders | Mar 13, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Mar 13, 2024 | — |
| DEF 14A | Proxy statement | Mar 13, 2024 | Apr 23, 2024 |
| 4 | Insider transaction | Mar 12, 2024 | Mar 11, 2024 |
| PRE 14A | Preliminary proxy statement | Mar 1, 2024 | Apr 23, 2024 |
| 4 | Insider transaction | Mar 1, 2024 | Feb 28, 2024 |
| 4 | Insider transaction | Feb 29, 2024 | Feb 27, 2024 |
| 144 | Notice of proposed sale | Feb 27, 2024 | — |
| 4 | Insider transaction | Feb 27, 2024 | Feb 23, 2024 |
| 4 | Insider transaction | Feb 22, 2024 | Feb 20, 2024 |
| 4 | Insider transaction | Feb 22, 2024 | Feb 20, 2024 |
| 4 | Insider transaction | Feb 22, 2024 | Feb 20, 2024 |
| 4 | Insider transaction | Feb 22, 2024 | Feb 20, 2024 |
| 4 | Insider transaction | Feb 22, 2024 | Feb 20, 2024 |
| 4 | Insider transaction | Feb 22, 2024 | Feb 20, 2024 |
| 4 | Insider transaction | Feb 22, 2024 | Feb 20, 2024 |
| 4 | Insider transaction | Feb 22, 2024 | Feb 20, 2024 |
| 4 | Insider transaction | Feb 22, 2024 | Feb 20, 2024 |
| 10-K | Annual report | Feb 20, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Feb 15, 2024 | Feb 15, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 13, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Jan 24, 2024 | — |
| 4/A | Primary document | Dec 21, 2023 | Dec 4, 2023 |
| 4 | Insider transaction | Dec 13, 2023 | Dec 11, 2023 |
| 4 | Insider transaction | Dec 8, 2023 | Dec 6, 2023 |
| 4 | Insider transaction | Dec 5, 2023 | Dec 1, 2023 |
| 8-K |
Current report
Material agreement
|
Nov 30, 2023 | Nov 27, 2023 |
| 4 | Insider transaction | Nov 2, 2023 | Oct 31, 2023 |
| 10-Q | Quarterly report | Oct 26, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Oct 26, 2023 | Oct 26, 2023 |
| 8-K/A |
Amended current report
Shareholder vote results
|
Sep 21, 2023 | Apr 25, 2023 |
| 4 | Insider transaction | Sep 1, 2023 | Aug 30, 2023 |
| 4 | Insider transaction | Aug 24, 2023 | Aug 22, 2023 |
| 4 | Insider transaction | Aug 15, 2023 | Aug 11, 2023 |
| 4 | Insider transaction | Aug 11, 2023 | Aug 9, 2023 |
| 4 | Insider transaction | Aug 10, 2023 | Aug 8, 2023 |
| 4 | Insider transaction | Aug 10, 2023 | Aug 8, 2023 |
| 144 | Notice of proposed sale | Aug 8, 2023 | — |
| 4 | Insider transaction | Aug 8, 2023 | Aug 2, 2023 |
| 10-Q | Quarterly report | Jul 27, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jul 27, 2023 | Jul 27, 2023 |
| 11-K | Employee savings plan report | Jun 28, 2023 | Dec 31, 2022 |
| 11-K | Employee savings plan report | Jun 28, 2023 | Dec 31, 2022 |
| 4 | Insider transaction | May 31, 2023 | May 30, 2023 |
| 4 | Insider transaction | May 31, 2023 | May 30, 2023 |
| SD | Specialized disclosure (conflict minerals) | May 25, 2023 | — |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- WST (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- PA
- Headquarters
- Exton, PA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 105770
- Former names
- WEST CO INC (until Feb 11, 1999)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.